News & Analysis on Clinical Trial Services & Contract Research And Development
The International Vaccine Institute plans to conduct a Phase III clinical trial for a typhoid conjugate vaccine as part of which it will put in place infrastructure and a robust training program, including good clinical practice training.
Using RWD and RWE to make data actionable and patient centric can be a gamechanger in the health care industry’s research capabilities, according to LMC Manna research executive.
Clinerion partners with Clinart to expand its footprint in the Middle East and North African region while advancing research in the area.
Medable has received $3.5m to further develop its end-to-end platform for digitally-enabled clinical trials, which can be used at an individual, study, or population level.
LabCorp’s Covance Drug Development segment is set to acquire Envigo’s nonclinical research services business for $485m – while Envigo will purchase Covance’s research products business.
CPhI North America donates $10,000 to iBIO’s Educate Center to help fund STEM programs for girls and solidifies its partnership with the association to support Illinois as a growing life sciences hub.
Hovione Technology reaches an agreement to acquire the global rights to a reusable, cost-efficient, dry-powder inhaler.
On the path to first-in-human clinical trials one of the main challenges is “velocity, ensuring rapid delivery of delivered drug product into the clinical program,” says CDMO.
CPhI 2019
Oncology and immunotherapies are the top two indications for global clinical research – and are driving a significant growth in the market demand for HPAPIs, says Patheon executive.
US FDA and Alvogen announce that lots of fentanyl patches will be recalled after packaging mislabels dose strength.
US FDA approves Aquestive’s oral film medication for the treatment of ALS using its PharmFilm technology.
Senator Flake will discuss regulatory guidance impacting innovation and his perspective on the state of the industry during his keynote address at CPhI North America.
NEWS IN BRIEF
Jordan-based MS Pharma announces the acquisition of the Greek generic manufacturer Genepharm, aiming to add cardiovascular, CNS and oncology products to its portfolio.